Clearone INC

ClearOne, Inc. has entered into material definitive agreements with four advisors, compensating them with company stock for past and ongoing advisory services.

ClearOne, Inc. announced the cancellation of warrants with First Finance Ltd. and finalized an employment agreement for its CFO, Simon Brewer, effective upon merger completion.

ClearOne, Inc. has entered into a definitive agreement to acquire Cortigent, Inc., a subsidiary of Vivani Medical, Inc., in a stock-for-stock merger transaction.

ClearOne, Inc. has entered into a loan agreement for up to $1,000,000 to support general working capital needs.

ClearOne, Inc. has successfully completed its reincorporation from Delaware to Nevada, effective April 22, 2026.

ClearOne, Inc. has terminated its corporate office lease, incurring a $300,000 fee, while simultaneously addressing a notice from Nasdaq regarding continued listing standards.

ClearOne, Inc. reported a significant net loss for Q3 and YTD 2025, driven by discontinued operations and an impairment charge, as it executes a strategic plan to sell its product business and become a reverse merger vehicle.

ClearOne, Inc. reports significant Q2 2025 losses and revenue decline, raising substantial doubt about its ability to continue as a going concern, prompting a strategic asset sale pursuit and workforce reduction.

ClearOne's Q1 2025 results reveal a significant revenue decline and increased net loss, raising substantial doubt about the company's ability to continue as a going concern.

ClearOne Inc. experienced a substantial 49% revenue decrease in the third quarter of 2024 compared to the same period last year, primarily due to reduced demand and the lingering effects of past production shortages.

ClearOne Inc. experienced a substantial revenue decrease in the second quarter of 2024, primarily due to production shortages and reduced demand across multiple regions.

ClearOne's first quarter 2024 results show a decrease in revenue and an increase in net loss compared to the same period last year, despite a slight improvement in gross profit margin.

ClearOne, Inc. has transitioned to a non-operating entity after selling its core assets, now focusing on strategic alternatives amidst significant financial challenges and a going concern warning.

ClearOne Inc. filed an amendment to its annual report on Form 10-K to include its policy for the recovery of erroneously awarded compensation, which was inadvertently omitted from the original filing.

ClearOne Inc.'s 2024 10-K filing reveals a substantial revenue decrease and a significant net loss, raising concerns about the company's ability to continue as a going concern.

ClearOne Inc. experienced a 26% revenue decrease in 2023, alongside a shift in manufacturing and strategic focus on core products and cost management.

First Finance Ltd. and 1 other reported changes in beneficial ownership of Clearone Inc common stock on August 4, 2026.

First Finance Ltd., a 10% owner and director, has agreed to acquire 437,500 shares of common stock and warrants for an additional 437,500 shares in ClearOne Inc. for $1.75 million.

A director and 10% owner of ClearOne Inc., Edward D. Bagley, sold 700,000 shares of common stock to an institutional investor affiliate in a privately negotiated transaction.

Director Edward Bagley purchased 2,000,000 shares of ClearOne Inc. at $0.50 per share, increasing his holdings to 12,590,528 shares.

ClearOne's Chief Financial Officer, Simon Brewer, acquired 100,000 incentive stock options on November 27, 2024.

ClearOne's CEO, Derek Graham, acquired 60,000 incentive stock options at an exercise price of $0.47 on November 27, 2024.

ClearOne, Inc. announces its 2025 Annual Meeting of Shareholders to be held virtually on December 29, 2025, focusing on the election of five directors and other business, following a significant net loss in 2024.

ClearOne is holding a special meeting to vote on proposals including increasing authorized shares, authorizing preferred stock, a reverse stock split, and allowing shareholder action by written consent.

ClearOne, Inc. has filed an S-1 registration statement detailing its proposed merger with Cortigent, Inc., a neurotechnology company, alongside a concurrent offering of units.

ClearOne Inc. reports the cancellation of a warrant by First Finance Ltd. as part of a merger agreement, maintaining a significant ownership stake.

First Finance Ltd., with Andrew Hromyk, has acquired a controlling 61.29% stake in ClearOne Inc. through a $1.75 million securities purchase agreement.

First Finance Ltd. and Andrew Hromyk now beneficially own 53.79% of ClearOne Inc.'s common stock after recent transactions.

Edward Dallin Bagley reduced his beneficial ownership in ClearOne Inc. to 8.2% after selling 700,000 shares to company affiliate First Finance Ltd. for $3.00 per share.

First Finance Ltd. and its principal, Andrew Hromyk, have acquired a 32.4% beneficial ownership stake in ClearOne Inc. through a $3 million convertible note purchase, leading to the appointment of two new directors to ClearOne's board.

Edward D. Bagley, a significant shareholder of ClearOne Inc., increased his beneficial ownership to 49.9% of the company's common stock by acquiring an additional 2,000,000 shares in a private placement.